Dario announces strategic partnership with amwell to expand access to its cardiometabolic digital therapeutic solution

New agreement integrates dario's cardiometabolic suite into amwell's market leading digital care delivery enablement platform covering over 90 million lives new york , march 22, 2023 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital therapeutics (dtx) market, announced today a strategic partnership with amwell ® (nyse: amwl), a leader in digital healthcare enablement, to deliver its cardiometabolic solution to amwell customers. dario's solution will be available through amwell beginning in the second half of 2023.
AMWL Ratings Summary
AMWL Quant Ranking